The FDA and EMA recognize the potential of AI in ADMET prediction, as long as models are transparent and well-validated. 6, 7 Yet significant challenges persist, particularly around inconsistent data ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback